Mycobacterium avium-intracellulare Infection: all 73 studies

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung DiseaseRecruitingNCT07647575Not applicable
• Clinical Characteristics and Immune Escape Mechanism of Nontuberculous Mycobacterial Lung Disease in South ChinaNot yet recruitingNCT07377864
• Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)RecruitingNCT07094711Phase 2
• M. Avium WGS During Mav-PD TreatmentRecruitingNCT06266442
• Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung DiseaseRecruitingNCT05824988
• Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary DiseaseRecruitingNCT05192057Phase 4
• IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)RecruitingNCT04294043Phase 1
• Study of Mycobacterial InfectionsRecruitingNCT00018044
• Study of Epetraborole in Patients With Treatment-refractory MAC Lung DiseaseTerminatedNCT05327803Phase 2/3Results posted
• Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexCompletedNCT04677543Phase 3Results posted
• Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary DiseaseTerminatedNCT04553406Phase 2Results posted
• A Study of Standard Drugs for Mycobacterium Avium ComplexCompletedNCT04287049Phase 2Results posted
• A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of MaravirocCompletedNCT01894776Phase 1Results posted
• Safety And Efficacy Of Rifabutin In HIV PatientsCompletedNCT00810446Results posted
• Evaluation of Sevoflurane Consumption During Initial Phase of Minimal-Flow Anesthesia in Retrograde Intrarenal SurgeryCompletedNCT07248917Not applicable
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation SuspensionTerminatedNCT06418711Phase 3
• A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary DiseaseCompletedNCT05496374Phase 2
• A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF PatientsCompletedNCT04685720Not applicable
• Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexCompletedNCT04677569Phase 3
• RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex DiseaseTerminatedNCT04616924Phase 3
• Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex DiseaseCompletedNCT03672630Phase 2/3
• Energy Metabolism for the Patients With Pulmonary Mycobacterium Avium ComplexCompletedNCT03550820
• Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium ComplexCompletedNCT03164291Phase 3
• A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccines ChAdOx2 HAV and MVA in Healthy Adult VolunteersCompletedNCT03027193Phase 1
• Haploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineCompletedNCT02996773Phase 1
• Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)Active, not recruitingNCT02968212Phase 2
• Program Cell Death Receptor 1 in Mycobacterium Avium Complex Lung DiseaseCompletedNCT02779049
• The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung DiseaseStatus unknownNCT02005094
• Improving Tolerance of Treatment of Pulmonary MAC InfectionsWithdrawnNCT01719042Phase 2
• Mycobacterium Avium Intracellulare Complex (MAC) StudyCompletedNCT00826423
• Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)CompletedNCT00652067
• Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)CompletedNCT00600769Phase 4
• Azithromycin in the Treatment of M. Avium Complex Lung DiseaseCompletedNCT00599079Phase 4
• Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung DiseaseCompletedNCT00598962Phase 4
• Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung DiseaseCompletedNCT00598897Phase 4
• Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium ParatuberculosisWithdrawnNCT00513552Phase 4
• Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex InfectionCompletedNCT00111397Phase 1
• A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex InfectionsCompletedNCT00021567Phase 2
• Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary DiseaseCompletedNCT00004689Phase 2
• A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDSCompletedNCT00002343Phase 4
• The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected PatientsCompletedNCT00002336Not applicable
• The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDSCompletedNCT00002331Not applicable
• A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected PatientsCompletedNCT00002309Not applicable
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled TrialCompletedNCT00002267Not applicable
• Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.CompletedNCT00002192Phase 2
• A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)CompletedNCT00002170Phase 2
• A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs PatientsCompletedNCT00002140Phase 3
• A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected PatientsCompletedNCT00002122Phase 3
• Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIVCompletedNCT00002104Phase 1
• A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or PlaceboCompletedNCT00002101Phase 3
• An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)CompletedNCT00002090Not applicable
• An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current TherapyCompletedNCT00002089Not applicable
• A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available TherapyCompletedNCT00002085Not applicable
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND StudyCompletedNCT00002080Not applicable
• A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV DiseaseCompletedNCT00002058Not applicable
• Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot StudyCompletedNCT00002037Not applicable
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled TrialCompletedNCT00002032Not applicable
• A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDSCompletedNCT00001995Not applicable
• Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex InfectionCompletedNCT00001763Phase 1
• A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDSCompletedNCT00001058Phase 2
• Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDSCompletedNCT00001047Phase 3
• Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected PatientsCompletedNCT00001039Phase 2
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected PatientsCompletedNCT00001030Phase 3
• The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected PatientsCompletedNCT00001023Not applicable
• The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDSCompletedNCT00000971Phase 1
• A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive PatientsCompletedNCT00000947Not applicable
• Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048CompletedNCT00000933
• A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive PatientsCompletedNCT00000907
• A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV InfectionCompletedNCT00000895Not applicable
• Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV TherapyCompletedNCT00000883Not applicable
• The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected PatientsCompletedNCT00000860
• A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDSCompletedNCT00000644Phase 2
• A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.CompletedNCT00000641Phase 2

← Mycobacterium avium-intracellulare Infection overview